Hymecromone Promotes Longevity and Insulin Sensitivity in Mice

Given that the extracellular matrix polymer hyaluronan (HA) has been implicated in longevity, we asked whether 4-methylumbelliferone (4-MU), an inhibitor of HA synthesis, impacts lifespan in mice. We designed a prospective study of long-term administration of 4-MU with conventional C57BL/6J mice. We find that 4-MU extends median survival from 122 weeks (control) to 154 weeks (4-MU), an increase of 32 weeks (<i>p</i> < 0.0001 by Log-rank Mantel Cox test). The maximum lifespan of 4-MU treated mice increased from 159 to 194 weeks. In tandem with these effects, 4-MU enhances insulin sensitivity, a metabolic parameter known to regulate lifespan, as measured by insulin tolerance testing (ITT) as well as frequent sampling intra venous glucose tolerance tests (FSIVGTTs). We further observed that 4-MU treated mice weigh less while consuming the same amount of food, indicating that 4-MU treatment alters energy expenditure. However, we do not observe changes in tissue HA content in this model. We conclude that 4-MU promotes insulin sensitivity and longevity but that the underlying mechanism, and the contribution of HA is unclear. 4-MU, already approved in various countries for hepatobiliary conditions, is currently under investigation and clinical development as a therapy for several chronic inflammatory conditions. These data suggest that the beneficial effects of 4-MU on tissue metabolism may include effects on longevity.

Authors

Institutions

Publication Details

Journal
Cells
Published
2024-10-18
DOI
https://doi.org/10.3390/cells13201727
Citations
2
Primary Topic
Adipose Tissue and Metabolism
Type
article
Field-Weighted Citation Impact
0.65

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hymecromone Promotes Longevity and Insulin Sensitivity in Mice

Nadine Nagy, Anissa Kalinowski, Stavros Garantziotis, Nina Pennetzdorfer et al.
2 citations
Cells
Adipose Tissue and Metabolism
0.65
article

Hymecromone Promotes Longevity and Insulin Sensitivity in Mice

Nadine Nagy, Anissa Kalinowski, Stavros Garantziotis, Nina Pennetzdorfer, Joshua W. Knowles, Thomas N. Wight, Darko Stefanovski, Kathryn S. Czepiel, Saranya Chidambaranathan Reghupaty, Paul L. Bollyky, Hunter A. Martinez, Rudolph D. Paladini, Payton L. Marshall, Rebecca L. Hull-Meichle, Aviv Hargil, Gernot Kaber, Robert B. Vernon, Carlos Medina, Robert W. Targ
article en
2 citations

Abstract

Given that the extracellular matrix polymer hyaluronan (HA) has been implicated in longevity, we asked whether 4-methylumbelliferone (4-MU), an inhibitor of HA synthesis, impacts lifespan in mice. We designed a prospective study of long-term administration of 4-MU with conventional C57BL/6J mice. We find that 4-MU extends median survival from 122 weeks (control) to 154 weeks (4-MU), an increase of 32 weeks (<i>p</i> < 0.0001 by Log-rank Mantel Cox test). The maximum lifespan of 4-MU treated mice increased from 159 to 194 weeks. In tandem with these effects, 4-MU enhances insulin sensitivity, a metabolic parameter known to regulate lifespan, as measured by insulin tolerance testing (ITT) as well as frequent sampling intra venous glucose tolerance tests (FSIVGTTs). We further observed that 4-MU treated mice weigh less while consuming the same amount of food, indicating that 4-MU treatment alters energy expenditure. However, we do not observe changes in tissue HA content in this model. We conclude that 4-MU promotes insulin sensitivity and longevity but that the underlying mechanism, and the contribution of HA is unclear. 4-MU, already approved in various countries for hepatobiliary conditions, is currently under investigation and clinical development as a therapy for several chronic inflammatory conditions. These data suggest that the beneficial effects of 4-MU on tissue metabolism may include effects on longevity.

CellsVol. 13(20)
University of Washington (US), Cardiovascular Institute of the South (US), VA Puget Sound Health Care System (US), National Institute of Environmental Health Sciences (US), System Biosciences (United States) (US), Benaroya Research Institute, University of Pennsylvania (US), Stanford University (US)
Stanford Diabetes Research Center, National Institutes of Health
Openalex Percentile: Top 28%
Adipose Tissue and Metabolism
0.65
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.